TipRanks on MSN

Sanofi’s amlitelimab study: A new hope for atopic dermatitis treatment?

Sanofi ($SNYNF) announced an update on their ongoing clinical study. Sanofi’s recent clinical study, officially titled ‘A Phase 3, Randomized, ...

Emirates Drug Establishment Approves Tapinarof Cream 1%, A New Treatment For Plaque Psoriasis In Adults And Atopic Dermatitis In Adults And Children 2 Years Of …

Emirates Drug Establishment Approves Tapinarof Cream 1%, A New Treatment For Plaque Psoriasis In Adults And Atopic Dermatitis ...
TipRanks on MSN

Organon launches phase 3 study on tapinarof cream for atopic dermatitis in infants

Organon & Co. ($OGN) announced an update on their ongoing clinical study. Organon & Co. has initiated a Phase 3 clinical study titled A ...

Kymera Therapeutics Unveils Promising Phase 1b Trial Results

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

Psoriasis research has revealed a link between fat metabolism and skin inflammation

A research team led by Erwin Wagner, a specialist at the Department of Dermatology and Laboratory Medicine at the Medical ...

Dupixent For Moderate-To-Severe Asthma Treatment Market Expected To Reach ~$8.1 Billion By 2032

Dupixent For Moderate-To-Severe Asthma Treatment Market Expected To Reach ~$8.1 Billion By 2032. December 13, 2025 7:27 am - The Dupixent market for moderate-to-severe asthma is valued at $3.25 ...